Procyanidin B-2 (Apple Polyphenol) for Hair Loss Telogen

Verdict: Unverified for telogen effluvium: no direct evidence

There is no clinical evidence that procyanidin B-2 (apple polyphenol) treats telogen effluvium. Every human trial to date studied male-pattern hair loss, not this condition, so its effectiveness for telogen effluvium remains unproven.

U ⚫ U Unverified Insufficient Evidence

🔬Why this grade7-layer evidence engine

This pair earns an Unverified rating because not a single study has tested procyanidin B-2 in telogen effluvium patients. The only human data are two small, double-blind trials (PMID 11406858, n=29; PMID 11194183, n=29) of 1% topical procyanidin B-2 in men with androgenetic alopecia. Both reported modest hair-count gains, but they were run by one research group, funded by the apple-polyphenol supplier, and judged low quality. Applying them to telogen effluvium is off-label extrapolation, not proof.

The only link to telogen biology is a laboratory study (PMID 11841365) showing procyanidin B-2 down-regulates telogen-specific PKC isozymes and speeds the telogen-to-anagen shift in mice. That is a plausible mechanism, but a preclinical signal in mice cannot establish a clinical effect in people.

Authorities offer no support either. The US FDA recognizes apple polyphenol extract only as a safe food ingredient, with no drug or hair-growth approval, and the EU EFSA concluded a cause-and-effect relationship has not been established for proanthocyanidins. Mayo Clinic, Cleveland Clinic, Harvard, and the AAD never address it; the AAD notes telogen effluvium hair usually regrows once the trigger is resolved, making any benefit hard to distinguish from natural recovery.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.38
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
U · Insufficient Evidence
Confidence
85%
Highly consistent evidence
Evidence level
E6
Multiple smaller RCTs (n<500)

How strongly each layer supports this effect

lower = less supportive
L11 AI re-checkIndependent read
0.20
L2 PubMedPrimary literature
0.40
L1 ExamineGlobal benchmark
0.50
L3 MechanismPlausibility
0.50
L5 Clinical bodiesAuthoritative stance
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.376
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — D 級條件未達 (需 E1-E3 negative;實際 E6)
  5. detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (3)L2 · primary research & systematic reviews

The first clinical trial of topical application of procyanidin B-2 to investigate its potential as a hair growing agent (Takahashi et al.)
PMID: 11406858 2001 RCT (double-blind) n = 29
Finding: Treatment vs placebo: 78.9% vs 30.0% showed increased mean hair diameter (p<0.02); hair count change +3.67±4.09 vs −2.54±4.00 hairs/0.25 cm² (p<0.001). Population was male androgenetic alopecia (AGA), NOT telogen effluvium.
🟠 Limited quality ⚠️ Industry-funded Effect size: +6.21 hairs/0.25 cm² vs placebo
View on PubMed
Investigation of topical application of procyanidin B-2 from apple to identify its potential use as a hair growing agent (Takahashi et al.)
PMID: 11194183 2000 RCT (double-blind) n = 29
Finding: Total hair increase: +6.68±5.53 (treatment) vs +0.08±4.56 (placebo), p<0.005; terminal hair increase: +1.99±2.58 vs −0.82±3.40, p<0.02. Same Kyowa Hakko group; population again male AGA, NOT telogen effluvium.
🟠 Limited quality ⚠️ Industry-funded Effect size: +6.60 hairs/0.25 cm² vs placebo
View on PubMed
Procyanidin B-2, extracted from apples, promotes hair growth: a laboratory study (Kamimura & Takahashi)
PMID: 11841365 2002 Other
Finding: Procyanidin B-2 down-regulates PKC isozymes expressed in a telogen-specific manner and accelerates telogen→anagen transition in shaved C3H mouse dorsal skin. Mechanistically relevant to TE but no human TE data.
🟠 Limited quality ⚠️ Industry-funded
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
Apple polyphenol extract (Applephenon) is generally recognized as safe (GRAS) under the intended conditions of use as a food ingredient source↗
L4b EU EFSA
Against
a cause and effect relationship has not been established between the consumption of proanthocyanidins from various sources and the maintenance of normal blood pressure / maintenance of normal blood flow / protection of body lipids from oxidative damage / maintenance of normal vascular function source↗
L4d TW TFDA / 衛福部
Neutral
本署公告之健康食品保健功效項目共十三項:護肝(針對化學性肝損傷)、抗疲勞、調節血脂、調節血糖、免疫調節、骨質保健、牙齒保健、延緩衰老、促進鐵吸收、胃腸功能改善、輔助調節血壓、不易形成體脂肪、輔助調整過敏體質。食品(含一般食品及健康食品)之標示、宣傳或廣告,不得有不實、誇張或易生誤解之情形,亦不得涉及醫療效能。 source↗
L5e Specialty Society (condition-mapped)
Not addressed
In most cases, the hair grows back once the cause of the hair loss has been addressed. source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬3 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-hair-loss-telogen-INT-procyanidin-b-2-001 繁體中文版 →